Advertisement

Topics

Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market by Geography and Forecast to 2020, Published by iHealthcareAnalyst Inc.

22:00 EST 26 Feb 2017 | PR.com

Maryland Heights, MO, February 27, 2017 --(PR.com)-- The global drug eluting beads, microcatheters and radiopaque beads in interventional oncology market is estimated to reach nearly USD 11.2 Billion in 2020, expanding at a CAGR of 8.6% from 2016 to 2020.

Browse Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market by Geography North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World and Forecast 2016-2020 at https://www.ihealthcareanalyst.com/report/drug-eluting-beads-microcatheters-radiopaque-beads-interventional-oncology-market/.

Drug-eluting bead transarterial chemoembolization (DEB-TACE) is a novel therapy for the treatment of hypervascuarized tumours. Through the intra-arterial delivery of microspheres, DEB-TACE allows for embolization as well as local release of chemotherapy in the treatment of hepatic malignancy, providing an alternative therapeutic option in unresectable tumours. Drug-eluting bead TACE is becoming more widely utilized in primary and liver-dominant metastatic disease of the liver. Microcatheters, are thin wall, small diameter catheters and delivery devices used in minimally invasive applications. These small catheters are ideal for navigating the vast network of tiny veins found within the body. Microcatheters are employed extensively in the neurovascular and cardiovascular fields. They are most commonly used in small vessel or selective diagnostic and interventional procedures, where an application requires an ultra-thin device for delivery, diagnosis, or mapping, a microcatheter is used. Radiopaque beads provide a practical solution for real time display of embolic material or drug delivery. These beads provide better conspicuity in determining the target during embolization and also allow optimal balance and delivery performance.

The global drug eluting beads, microcatheters and radiopaque beads in interventional oncology market report estimates the market size (Revenue USD million – 2013 to 2020) by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World and forecasts growth trends (CAGR% – 2016 to 2020). The global drug eluting beads, microcatheters and radiopaque beads in interventional oncology market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.

Major players operating the global drug eluting beads, microcatheters and radiopaque beads in interventional oncology market and profiled in this report include Abbott Laboratories (Abbott EP), ABK Biomedical, Inc., Boston Scientific Corporation, BTG plc, Cook Medical, Inc., Medtronic, Inc., Merit Medical Systems, Inc., Stryker Corporation, Surefire Medical, Inc., Terumo Corporation, and Vascular Solutions, Inc.

To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/drug-eluting-beads-microcatheters-radiopaque-beads-interventional-oncology-market/

About Us
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
Website: https://www.ihealthcareanalyst.com

Contact Information:
iHealthcareAnalyst, Inc.
Ana Aitawa
(314) 500-7508
Contact via Email
https://www.ihealthcareanalyst.com/

Read the full story here: http://www.pr.com/press-release/706863

Press Release Distributed by PR.com

Original Article: Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market by Geography and Forecast to 2020, Published by iHealthcareAnalyst Inc.

NEXT ARTICLE

More From BioPortfolio on "Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market by Geography and Forecast to 2020, Published by iHealthcareAnalyst Inc."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...